Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCHR1 | Q99705 | 20/20 | 0.81 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL385802 | 0.99 | MCHR1 (0.79) | MCHR1CYP3A4CYP2C19KCNH2 | |
| SCHEMBL384787 | 0.90 | MCHR1 (0.81) | MCHR1CYP3A4CYP2C19KCNH2 | |
| Hydrochloric Acid SCHEMBL385662 | 0.90 | MCHR1 (0.79) | MCHR1CYP3A4CYP2C19KCNH2 | |
| SCHEMBL385282 | 0.89 | MCHR1 (1.00) | MCHR1CYP3A4CYP2C19 | |
| Hydrochloric Acid SCHEMBL385472 | 0.89 | MCHR1 (0.98) | MCHR1CYP3A4CYP2C19 | |
| SCHEMBL10049567 | 0.88 | MCHR1 (1.00) | MCHR1CYP3A4KCNH2 | |
| Hydrochloric Acid SCHEMBL384897 | 0.87 | MCHR1 (0.98) | MCHR1CYP3A4KCNH2 | |
| SCHEMBL10049559 | 0.87 | MCHR1 (0.85) | MCHR1CYP3A4CYP2C19 | |
| Hydrochloric Acid SCHEMBL385783 | 0.86 | MCHR1 (0.84) | MCHR1CYP3A4CYP2C19 | |
| SCHEMBL10049556 | 0.86 | MCHR1 (0.85) | MCHR1CYP3A4CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8101632-B2 | 5-furopyridinone substituted indazoles | ALBANY MOLECULAR RESEARCH, INC. (US) | 2012-01-24 | — | — | US | disclosed |
| US-8101632-B2 | 5-furopyridinone substituted indazoles | ALBANY MOLECULAR RESEARCH, INC. (US) | 2012-01-24 | — | — | US | disclosed |
| US-20090318439-A1 | 5-FUROPYRIDINONE SUBSTITUTED INDAZOLES | ALBANY MOLECULAR RESEARCH, INC. (US) | 2009-12-24 | — | — | US | disclosed |
| US-20090318439-A1 | 5-FUROPYRIDINONE SUBSTITUTED INDAZOLES | ALBANY MOLECULAR RESEARCH, INC. (US) | 2009-12-24 | — | — | US | disclosed |
| WO-2008086409-A1 | 5-FUROPYRIDINONE SUBSTITUTED INDAZOLES | ALBANY MOLECULAR RESEARCH, INC. (US) | 2008-07-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090318439-A1 | 5-FUROPYRIDINONE SUBSTITUTED INDAZOLES | MCHR1, PRMT5, PRMT1 | MCHR1 1/4885CYP3A4 2482/4885CYP2C19 3826/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.